# reload+after+2024-01-20 23:32:31.458196
phone§(202) 684-6383
longBusinessSummary§The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
maxAge§86400
priceHint§4
yield§0.0023999999
totalAssets§6426299
navPrice§1.398
currency§USD
category§Miscellaneous Sector
ytdReturn§0.035971202
beta3Year§0.0
fundFamily§AdvisorShares
fundInceptionDate§1631664000
legalType§Exchange Traded Fund
exchange§PCX
quoteType§ETF
shortName§AdvisorShares Psychedelics ETF
longName§AdvisorShares Psychedelics ETF
firstTradeDateEpochUtc§1631799000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§4afd5bce-40d3-3c58-9cad-eab5c6073d10
gmtOffSetMilliseconds§-18000000
trailingPegRatio§None
